Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 1 | 16 | 2022 | 3336 | 1.040 |
Why?
|
Hypoglycemic Agents | 13 | 2024 | 2872 | 0.790 |
Why?
|
Diabetes Mellitus, Type 2 | 20 | 2024 | 11725 | 0.750 |
Why?
|
Clinical Nursing Research | 2 | 2012 | 16 | 0.750 |
Why?
|
Taurine | 2 | 2019 | 94 | 0.750 |
Why?
|
Research Personnel | 2 | 2017 | 573 | 0.710 |
Why?
|
Ethics, Nursing | 1 | 2017 | 25 | 0.600 |
Why?
|
Codon, Terminator | 1 | 2017 | 127 | 0.580 |
Why?
|
Blood Glucose | 16 | 2024 | 6256 | 0.480 |
Why?
|
Metformin | 6 | 2024 | 835 | 0.460 |
Why?
|
Legal Guardians | 1 | 2012 | 56 | 0.430 |
Why?
|
Third-Party Consent | 1 | 2012 | 64 | 0.430 |
Why?
|
Diabetic Angiopathies | 2 | 2014 | 818 | 0.410 |
Why?
|
Community-Based Participatory Research | 1 | 2012 | 214 | 0.370 |
Why?
|
Diabetes Complications | 5 | 2022 | 1359 | 0.370 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2019 | 9959 | 0.360 |
Why?
|
Joint Diseases | 1 | 2014 | 480 | 0.350 |
Why?
|
Protein Biosynthesis | 1 | 2017 | 2126 | 0.350 |
Why?
|
Professional Role | 1 | 2012 | 306 | 0.340 |
Why?
|
Sulfonylurea Compounds | 4 | 2024 | 204 | 0.340 |
Why?
|
Insulin | 10 | 2024 | 6580 | 0.340 |
Why?
|
Multicenter Studies as Topic | 2 | 2014 | 1677 | 0.320 |
Why?
|
Musculoskeletal Diseases | 1 | 2014 | 581 | 0.310 |
Why?
|
Models, Nursing | 1 | 2007 | 44 | 0.310 |
Why?
|
Nursing Research | 1 | 2007 | 77 | 0.290 |
Why?
|
Injections, Subcutaneous | 2 | 2008 | 666 | 0.290 |
Why?
|
Zebrafish | 1 | 2017 | 2994 | 0.270 |
Why?
|
Gender Identity | 1 | 2010 | 688 | 0.240 |
Why?
|
Nursing Staff, Hospital | 1 | 2007 | 346 | 0.240 |
Why?
|
Blood Glucose Self-Monitoring | 4 | 2022 | 434 | 0.240 |
Why?
|
Insulin Resistance | 2 | 2023 | 3864 | 0.210 |
Why?
|
Self Care | 3 | 2019 | 786 | 0.200 |
Why?
|
Hyperglycemia | 3 | 2022 | 1373 | 0.200 |
Why?
|
Benchmarking | 1 | 2007 | 1042 | 0.190 |
Why?
|
Glucose | 1 | 2012 | 4397 | 0.190 |
Why?
|
Bass | 1 | 2019 | 7 | 0.180 |
Why?
|
Hospitals, General | 4 | 2012 | 749 | 0.170 |
Why?
|
Intensive Care Units | 1 | 2012 | 3679 | 0.170 |
Why?
|
Attitude to Health | 1 | 2008 | 2052 | 0.170 |
Why?
|
Cysteic Acid | 1 | 2017 | 2 | 0.150 |
Why?
|
Carboxy-Lyases | 1 | 2017 | 90 | 0.150 |
Why?
|
Cardiovascular Diseases | 5 | 2022 | 15165 | 0.150 |
Why?
|
Biomedical Research | 1 | 2012 | 3309 | 0.150 |
Why?
|
Pamphlets | 1 | 2017 | 75 | 0.150 |
Why?
|
Vision, Ocular | 1 | 2019 | 464 | 0.130 |
Why?
|
Evidence-Based Medicine | 1 | 2007 | 3610 | 0.130 |
Why?
|
Lost to Follow-Up | 1 | 2015 | 105 | 0.130 |
Why?
|
Coronary Disease | 1 | 2010 | 6077 | 0.130 |
Why?
|
Diabetes Mellitus | 3 | 2012 | 5751 | 0.130 |
Why?
|
Patient Advocacy | 1 | 2017 | 353 | 0.120 |
Why?
|
Healthcare Disparities | 1 | 2010 | 3158 | 0.120 |
Why?
|
Hearing Loss | 2 | 2019 | 765 | 0.120 |
Why?
|
Cystic Fibrosis | 1 | 2022 | 1177 | 0.110 |
Why?
|
Gastroparesis | 1 | 2015 | 131 | 0.110 |
Why?
|
Gastric Emptying | 1 | 2015 | 233 | 0.110 |
Why?
|
Hashimoto Disease | 1 | 2014 | 97 | 0.110 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2017 | 3923 | 0.110 |
Why?
|
Boston | 2 | 2017 | 9313 | 0.100 |
Why?
|
Point Mutation | 1 | 2017 | 1623 | 0.100 |
Why?
|
Humans | 40 | 2024 | 744343 | 0.100 |
Why?
|
Erectile Dysfunction | 1 | 2015 | 461 | 0.100 |
Why?
|
Amino Acids | 1 | 2017 | 1736 | 0.100 |
Why?
|
Adolescent Health Services | 1 | 2013 | 215 | 0.100 |
Why?
|
Massachusetts | 4 | 2012 | 8663 | 0.090 |
Why?
|
Comparative Effectiveness Research | 3 | 2022 | 681 | 0.090 |
Why?
|
Inpatients | 2 | 2012 | 2518 | 0.090 |
Why?
|
Middle Aged | 20 | 2023 | 213383 | 0.090 |
Why?
|
Interviews as Topic | 1 | 2017 | 2539 | 0.090 |
Why?
|
Career Mobility | 1 | 2012 | 262 | 0.090 |
Why?
|
Needs Assessment | 2 | 2013 | 1147 | 0.090 |
Why?
|
Automation | 1 | 2012 | 584 | 0.090 |
Why?
|
Patient Education as Topic | 2 | 2017 | 2278 | 0.080 |
Why?
|
Patient Compliance | 3 | 2019 | 2684 | 0.080 |
Why?
|
Prediabetic State | 1 | 2014 | 499 | 0.080 |
Why?
|
Male | 26 | 2023 | 350118 | 0.080 |
Why?
|
Follow-Up Studies | 6 | 2019 | 39050 | 0.080 |
Why?
|
Adult | 17 | 2022 | 214055 | 0.080 |
Why?
|
Job Satisfaction | 1 | 2012 | 535 | 0.080 |
Why?
|
Female | 27 | 2023 | 380194 | 0.080 |
Why?
|
Nursing Evaluation Research | 1 | 2007 | 26 | 0.080 |
Why?
|
Qualitative Research | 1 | 2017 | 2682 | 0.080 |
Why?
|
Diabetic Retinopathy | 2 | 2015 | 1210 | 0.080 |
Why?
|
Nursing Methodology Research | 1 | 2007 | 67 | 0.080 |
Why?
|
Lipids | 3 | 2021 | 3305 | 0.080 |
Why?
|
Education, Nursing, Continuing | 1 | 2007 | 75 | 0.080 |
Why?
|
Risk Factors | 9 | 2022 | 72290 | 0.080 |
Why?
|
Blood Pressure | 5 | 2021 | 8554 | 0.070 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 25043 | 0.070 |
Why?
|
Drug Therapy, Combination | 3 | 2022 | 6489 | 0.070 |
Why?
|
Cohort Studies | 6 | 2022 | 40561 | 0.070 |
Why?
|
Disability Evaluation | 1 | 2014 | 1827 | 0.070 |
Why?
|
Health Education | 1 | 2013 | 1056 | 0.070 |
Why?
|
Clinical Protocols | 1 | 2012 | 1462 | 0.070 |
Why?
|
Continuity of Patient Care | 1 | 2013 | 1049 | 0.070 |
Why?
|
Menopause | 1 | 2013 | 1626 | 0.070 |
Why?
|
Amino Acid Sequence | 1 | 2017 | 13815 | 0.060 |
Why?
|
Prevalence | 3 | 2020 | 15226 | 0.060 |
Why?
|
Longitudinal Studies | 4 | 2015 | 13989 | 0.060 |
Why?
|
Hypertension | 2 | 2022 | 8480 | 0.060 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 2 | 2022 | 293 | 0.060 |
Why?
|
Adolescent Behavior | 1 | 2013 | 1151 | 0.060 |
Why?
|
Cholesterol, LDL | 2 | 2010 | 2356 | 0.060 |
Why?
|
Research Design | 1 | 2019 | 5987 | 0.060 |
Why?
|
Aged | 9 | 2023 | 163280 | 0.060 |
Why?
|
Cognition | 3 | 2023 | 6770 | 0.060 |
Why?
|
Leadership | 1 | 2012 | 1357 | 0.050 |
Why?
|
Diffusion of Innovation | 1 | 2007 | 725 | 0.050 |
Why?
|
Safety Management | 1 | 2007 | 783 | 0.050 |
Why?
|
Employment | 1 | 2008 | 1132 | 0.050 |
Why?
|
Self Report | 1 | 2012 | 3558 | 0.050 |
Why?
|
Triglycerides | 1 | 1988 | 2454 | 0.050 |
Why?
|
Young Adult | 6 | 2022 | 56430 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2010 | 2046 | 0.050 |
Why?
|
Dyslipidemias | 2 | 2022 | 849 | 0.050 |
Why?
|
Sex Factors | 2 | 2014 | 10397 | 0.050 |
Why?
|
Depressive Disorder | 2 | 2015 | 3748 | 0.050 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 7913 | 0.040 |
Why?
|
Patient Discharge | 1 | 2012 | 3313 | 0.040 |
Why?
|
Patient Selection | 1 | 2012 | 4215 | 0.040 |
Why?
|
Animal Feed | 1 | 2019 | 110 | 0.040 |
Why?
|
Fisheries | 1 | 2019 | 34 | 0.040 |
Why?
|
Disease Management | 1 | 2010 | 2459 | 0.040 |
Why?
|
Analysis of Variance | 3 | 2013 | 6365 | 0.040 |
Why?
|
Diabetic Neuropathies | 1 | 2022 | 400 | 0.040 |
Why?
|
Albuminuria | 1 | 2022 | 682 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2012 | 3843 | 0.040 |
Why?
|
Microvessels | 1 | 2022 | 544 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2017 | 57776 | 0.040 |
Why?
|
Adolescent | 8 | 2019 | 85781 | 0.040 |
Why?
|
Quality of Life | 2 | 2015 | 12804 | 0.040 |
Why?
|
Cholesterol, HDL | 1 | 2022 | 1814 | 0.030 |
Why?
|
Time Factors | 2 | 2015 | 40075 | 0.030 |
Why?
|
Infusion Pumps, Implantable | 1 | 1996 | 156 | 0.030 |
Why?
|
Body Mass Index | 3 | 2023 | 12720 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2022 | 2170 | 0.030 |
Why?
|
Poverty Areas | 1 | 2015 | 275 | 0.030 |
Why?
|
Insulin Infusion Systems | 1 | 2015 | 212 | 0.030 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2014 | 101 | 0.030 |
Why?
|
Insulin, Long-Acting | 1 | 2013 | 57 | 0.030 |
Why?
|
Self Efficacy | 1 | 2017 | 616 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2019 | 1660 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1125 | 0.030 |
Why?
|
Age of Onset | 1 | 2019 | 3271 | 0.030 |
Why?
|
Algorithms | 1 | 2012 | 13881 | 0.020 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2013 | 340 | 0.020 |
Why?
|
Urinary Incontinence | 1 | 2015 | 496 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2007 | 7279 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 2013 | 5391 | 0.020 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2015 | 685 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2013 | 1423 | 0.020 |
Why?
|
Microcirculation | 1 | 2013 | 1286 | 0.020 |
Why?
|
Hypoglycemia | 1 | 1996 | 861 | 0.020 |
Why?
|
Animals | 2 | 2019 | 168757 | 0.020 |
Why?
|
Perception | 1 | 2015 | 1198 | 0.020 |
Why?
|
Remission Induction | 1 | 2014 | 2386 | 0.020 |
Why?
|
Body Weight | 1 | 2019 | 4669 | 0.020 |
Why?
|
Retina | 1 | 2019 | 2616 | 0.020 |
Why?
|
Diabetic Nephropathies | 1 | 2015 | 984 | 0.020 |
Why?
|
Triazoles | 1 | 2013 | 911 | 0.020 |
Why?
|
Intelligence Tests | 1 | 1988 | 505 | 0.020 |
Why?
|
Random Allocation | 1 | 2012 | 2429 | 0.020 |
Why?
|
Pyrazines | 1 | 2013 | 1230 | 0.020 |
Why?
|
Professional-Patient Relations | 1 | 2012 | 737 | 0.020 |
Why?
|
Efficiency, Organizational | 1 | 2012 | 695 | 0.020 |
Why?
|
Child | 4 | 2019 | 77709 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2012 | 956 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4933 | 0.020 |
Why?
|
United States | 3 | 2018 | 69872 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12354 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2022 | 63114 | 0.010 |
Why?
|
Social Support | 1 | 2013 | 2118 | 0.010 |
Why?
|
Health Status | 1 | 2015 | 4034 | 0.010 |
Why?
|
Reaction Time | 1 | 1988 | 2097 | 0.010 |
Why?
|
Weight Gain | 1 | 2012 | 2292 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9687 | 0.010 |
Why?
|
Weight Loss | 1 | 2012 | 2622 | 0.010 |
Why?
|
Cholesterol | 1 | 1988 | 2917 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12245 | 0.010 |
Why?
|
Heart Failure | 1 | 2022 | 10900 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 21746 | 0.010 |
Why?
|
Exercise | 1 | 2013 | 5615 | 0.010 |
Why?
|
Metabolic Clearance Rate | 1 | 1996 | 380 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 1996 | 425 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 20947 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13408 | 0.010 |
Why?
|
Diet | 1 | 2013 | 7939 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1996 | 2274 | 0.010 |
Why?
|
Eating | 1 | 1996 | 1536 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 1996 | 1901 | 0.000 |
Why?
|
Obesity | 1 | 1988 | 12745 | 0.000 |
Why?
|
Concepts
(190)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_